Awardee OrganizationHEBREW REHABILITATION CENTER FOR AGED
Description
Abstract Text
DESCRIPTION: (Adapted from Investigator's Abstract) Osteoporosis and
related fractures represent major public health problems that will only
increase in importance as the population ages. Several studies have now
convincingly demonstrated that aging-related bone loss continues, and may
even accelerate, in extreme old age. A better understanding of the factors
that may be unique to bone loss in old age may help to refine the types of
interventions to preserve bone mass in old age. The present application is
a competing continuation proposal from the Framingham osteoporosis study
group to examine in detail several risk factors for bone loss in old age
using three related cohorts, the original Framingham cohort, The Framingham
Offspring cohort and a new Framingham minority cohort. The Original
Framingham cohort has been the subject of two previous exams that included
measurement of bone density. The Framingham Offspring Cohort was recruited
from among the children, and their spouses, of members of the original
cohort starting in 1971; 3570 are expected to participate in this
osteoporosis study. The Minority cohort is currently being recruited and
will consist of 300 subjects (34% black and 66% Hispanic). The proposed
studies will extend and expand upon the research group s previous
investigations of more traditional risk factors for bone loss by taking
advantage of developments in nutritional assessment, as well as findings
from cellular and molecular biology of bone, which offer an opportunity to
examine risk factors for bone loss that have been less well studied.
The primary aim (1) of the proposed studies is to examine the effect of
dietary factors on bone health, in particular the effect on bone density and
bone loss of consumption choices among common food groups, and the effect on
bone loss of specific nutrients that have not been well-studied with regard
to bone, including magnesium, potassium, vitamin C, sodium, and vitamin K.
The dietary studies will be performed using longitudinal data on bone
density from the original Framingham cohort, and using cross-sectional bone
density data in the Offspring and Minority Cohorts. Dietary data, in the
form of food frequency questionnaires in all three cohorts, and 3 day food
records in the Offspring Cohort, have already been collected at previous
examinations. For this aim, follow-up for bone loss in the Original
Framingham Cohort will be extended from 4-5 years to 8 years by adding an
assessment of bone density at a planned future Framingham biennial
examination (Exam 24). A special call back visit will be required to obtain
bone density in all of the approximately 3,600 members of the Offspring
Cohort. Both dietary data and bone density are already being measured in an
ongoing examination of the Minority Cohort.
There are also several other Aims of the study, as follow: (2) to examine
the cross-sectional association of IGF-1 and IGF-BP4 with bone density in a
subset of 100 men and 100 women in the Framingham Offspring cohort using
blood specimens obtained 5 years prior to the measurement of bone density;
(3) to examine the cross-sectional association with bone density of two new
measures of weight-bearing physical activity, a validated questionnaire and
an automated weight-bearing activity monitor, in subsets of 200 men and 200
women in each of the Original and Offspring Cohorts; physical activity will
also be examined in relation to a new measurement of QUS of the heel in this
subset from the Original cohort; the physical activity measures will be
obtained in a special callback or regular visit in the Offspring Cohort and
at Exam 24 in the original cohort; and (4) to compare measures of
quantitative ultrasound (QUS) of the calcaneus between members of the
Original Cohort who attend Exam 24 and those who are unable to attend the
exam to determine if bone loss may be underestimated by studying subjects
who attend clinic examinations. QUS will be assessed with a new dry system
device in all those in the original cohort who attend Exam 24 as well as
those who receive the standard Framingham home visit.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ascorbate bone density bone fracture bone metabolism clinical research diet dietary sodium disease /disorder proneness /risk exercise human data longitudinal human study magnesium nutrition of aging nutrition related tag osteoporosis pathologic bone resorption potassium questionnaires vertebrae vitamin K
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
030832075
UEI
WS29EMGEVEJ4
Project Start Date
30-September-1991
Project End Date
31-August-2001
Budget Start Date
01-September-1999
Budget End Date
31-August-2000
Project Funding Information for 1999
Total Funding
$420,048
Direct Costs
$326,727
Indirect Costs
$93,321
Year
Funding IC
FY Total Cost by IC
1999
National Institute on Aging
$168,020
1999
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$252,028
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AR041398-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AR041398-09
Patents
No Patents information available for 5R01AR041398-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AR041398-09
Clinical Studies
No Clinical Studies information available for 5R01AR041398-09
News and More
Related News Releases
No news release information available for 5R01AR041398-09
History
No Historical information available for 5R01AR041398-09
Similar Projects
No Similar Projects information available for 5R01AR041398-09